Clarification sought from Brooks Laboratories Ltd
The Exchange has sought clarification from Brooks Laboratories Ltd with respect to news article appearing in The Economic Times on January 13, 2015 titled "SEBI Imposes 11.8 Crs. Penalty on Brooks Labs, Five Executives." The reply is awaited. Brooks Laboratories Ltd reply to clarification sought by Exchange
The Exchange had sought clarification from Brooks Laboratories Ltd with respect to news article appearing in Asian Age on December 03, 2014 titled "SEBI Passes order against 8 firms"Brooks Laboratories Ltd replied stating, "We would like to inform you that it is a matter of record that SEBI had passed an Ad Interim Ex-Parte Order against the Company on December 28, 2011. Subsequently, SEBI passed a Confirmatory Order in this regard on July... Clarification sought from Brooks Laboratories Ltd
The Exchange has sought clarification from Brooks Laboratories Ltd with respect to news article appearing in Asian Age on December 03, 2014 titled "SEBI Passes order against 8 firms."The reply is awaited. Financial Results & Limited Review for Sept 30, 2014 (Standalone)
Brooks Laboratories Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2014. Outcome of Board Meeting
Brooks Laboratories Ltd has informed BSE that Mr. Ketan Shah has resigned as the Chief Financial Officer of the Company with effect from October 09, 2014 and Mr. Anil Pillai has been appointed as the Chief Financial Officer of the Company with effect from November 01, 2014.The Board has accepted the resignation and have considered the appointment in its meeting held on October 30, 2014. Closure of Trading Window
Brooks Laboratories Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on November 14, 2014, inter alia, to consider and to approve Unaudited Financial Results for the quarter and half year ended September 30, 2014.Further, pursuant to the "Code of Conduct for Prohibition of Insider Trading" of Brooks Laboratories Limited, the Trading Window for dealing in the securities of the Company shall remain closed... Shareholding Pattern For September 30, 2014
Brooks Laboratories Ltd has informed BSE about the Shareholding Pattern as on September 30, 2014. Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Brooks Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Outcome of Board Meeting
Brooks Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 29, 2014, inter alia, has approved the following:1. Appointment of Ms. Sonia Gupta as Additional Independent Director of the Company with effect from September 29, 2014, and as a member of the Audit Committee, Stakeholder Relationship Committee and the Nomination & Remuneration Committee of the Board of Directors of the Company.... Updates on Outcome of AGM
Brooks Laboratories Ltd has submitted to BSE a copy of proceedings of the 12th Annual General Meeting of the Company held on August 08, 2014.